Showing 41,821 - 41,840 results of 65,058 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.30s Refine Results
  1. 41821

    Table2_Dynamic Epicardial Contribution to Cardiac Interstitial c-Kit and Sca1 Cellular Fractions.docx by C. Pogontke (12677213)

    Published 2022
    “…We found that a large proportion of cardiac c-Kit<sup>POS</sup> cells express specific markers strongly suggesting they are blood-borne cells. …”
  2. 41822

    Table3_Dynamic Epicardial Contribution to Cardiac Interstitial c-Kit and Sca1 Cellular Fractions.docx by C. Pogontke (12677213)

    Published 2022
    “…We found that a large proportion of cardiac c-Kit<sup>POS</sup> cells express specific markers strongly suggesting they are blood-borne cells. …”
  3. 41823

    Table5_Dynamic Epicardial Contribution to Cardiac Interstitial c-Kit and Sca1 Cellular Fractions.DOCX by C. Pogontke (12677213)

    Published 2022
    “…We found that a large proportion of cardiac c-Kit<sup>POS</sup> cells express specific markers strongly suggesting they are blood-borne cells. …”
  4. 41824
  5. 41825
  6. 41826

    BPLF1 selectively inhibits the detection of TOP2-induced DNA damage. by Jinlin Li (2267896)

    Published 2021
    “…The expression of catalytically active BPLF1 was associated with a significant decrease of Etoposide induced nuclear γH2AX fluorescence and decreased formation of 53BP1 foci. …”
  7. 41827
  8. 41828
  9. 41829
  10. 41830

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  11. 41831

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  12. 41832
  13. 41833
  14. 41834
  15. 41835
  16. 41836

    Effect of the surface charge of HN protein on its temperature-induced aggregation. by Yu Shang (49702)

    Published 2022
    “…T<sub>m-NA</sub> of protein at the indicated pH is shown as the temperature for a 50% decrease in NA activity of protein heat-treated for 10 min. …”
  17. 41837
  18. 41838
  19. 41839

    Subcutaneous Allo increased BrdU incorporation and PCNA protein expression in male mouse AD model. by Ronald W. Irwin (329648)

    Published 2015
    “…In 5-month-old 3xTgAD mouse hippocampus, protein expression of PCNA increased significantly at 4 h after transdermal (TD) Allo 50 mg/kg and SC Allo 10 mg/kg doses. D. In 15-month-old nonTg mouse hippocampus, protein expression of PCNA increased significantly at 4 h after TD Allo 50 mg/kg dose. …”
  20. 41840

    Table_1_Diabetic and Elder Patients Experience Superior Cardiovascular Benefits After Gastric Bypass Induced Weight Loss.DOCX by Pedro R. Pereira (6016460)

    Published 2018
    “…Patients with prior type 2 diabetes and aged 50 years or older experienced a significantly superior CV risk reduction, with diabetic patients experiencing a reduction of their 10–year CV disease risk of 3.58 ± 1.11% vs. a reduction of 1.31 ± 0.20% in non-diabetic patients and with the 10–year risk of CV disease dropping 3.41 ± 0.75% in patients older than 50 vs. a reduction of 0.99 ± 0.18 in patients up to 50 years. …”